Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
, 48 (12), 614-7

Steroid Therapy in Septic Shock. Survival Studies in a Laboratory Model

  • PMID: 6760756
Comparative Study

Steroid Therapy in Septic Shock. Survival Studies in a Laboratory Model

T C Fabian et al. Am Surg.


The efficacy of pharmacologic doses of steroids in the treatment of septic shock was evaluated using a laboratory model. The model produced a septic insult of gradual onset followed by a rapid progression, allowing for the evaluation of postcontamination therapeutic regimens. In Sprague-Dawley rats, the cecum was ligated distal to the ileocecal valve and doubly punctured. Control animals (n = 41) received no postoperative therapy. Mortality was 37 per cent at 24 hours and 90 per cent at 48 hours. Approximately 25 animals were assigned to each of five experimental groups. Pharmacologic doses of methylprednisolone at four and eight hours postoperatively did not alter survival. Short-term gentamicin (STG) at four and eight hours improved early survival, which then declined to control values. Addition of steroid to STG had no effect. Long-term gentamicin (LTG) administered through the third postoperative day produced significant increased survival over controls throughout the study. Pharmacologic doses of steroid at four and eight hours added to LTG resulted in a significant increase (P less than 0.05) in survival rate over the treatment with LTG alone.

Similar articles

See all similar articles

Cited by 5 PubMed Central articles

  • Corticosteroids for Treating Sepsis in Children and Adults
    D Annane et al. Cochrane Database Syst Rev 12 (12), CD002243. PMID 31808551. - Review
    Moderate-certainty evidence indicates that corticosteroids probably reduce 28-day and hospital mortality among patients with sepsis. Corticosteroids result in large reduc …
  • Immune Effects of Corticosteroids in Sepsis
    N Heming et al. Front Immunol 9, 1736. PMID 30105022. - Review
    Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammat …
  • Corticosteroids for Treating Sepsis
    D Annane et al. Cochrane Database Syst Rev 2015 (12), CD002243. PMID 26633262. - Review
    Overall, low-quality evidence indicates that corticosteroids reduce mortality among patients with sepsis. Moderate-quality evidence suggests that a long course of low-dos …
  • Scientific and Clinical Challenges in Sepsis
    L Ulloa et al. Curr Pharm Des 15 (16), 1918-35. PMID 19519432. - Review
    Advances in intensive care and antibiotics have prevented the spread of some infections, though sepsis mortality rates remain high. With failure of over thirty clinical t …
  • Increasing the Efficacy of Anti-Inflammatory Agents Used in the Treatment of Sepsis
    P Minneci et al. Eur J Clin Microbiol Infect Dis 22 (1), 1-9. PMID 12582737. - Review
    Excessive production of inflammatory mediators during invasive infection plays a key role in the pathogenesis of septic shock. In an attempt to improve survival of patien …

Publication types

LinkOut - more resources